Sebastian Amigorena

This inventor holds 12 USPTO granted patents and 29 published patent applications and 3 EPO patents. Top assignees: Institut Curie, National Institute of Health and Medical Research, Centre National De La Recherche Scientifique. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastian Amigorena. Retrieved from https://idiyas.com/inventor/sebastian-amigorena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 29)

% Patents Active = 75.0

EPO Patents = 3 (Patent Applications = 27)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 113(Granted Patents)

Company Filing History:

National Institute of Health and Medical Research

patents

7 out of 5,383

Centre National De La Recherche Scientifique

Anosys, Inc., Institute Curie

patent

6. 1 out of 101

Institut Gustave Roussy

patents

7. 1 out of 13

Institut National De La Sante Et De La Recherche Medicale

12. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622926 - Immunotherapy targeting tumor neoantigenic peptides (2026-05-12),

2. 12371471 - Immune cells defective for SUV39H1 (2025-07-29),

3. 12152077 - Immunotherapy targeting tumor neoantigenic peptides (2024-11-26),

4. 11622978 - Immune cells defective for SUV39H1 (2023-04-11),

5. 11285176 - Immune cells defective for Suv39h1 (2022-03-29),

6. 10968281 - Anti-LSP1 antibody (2021-04-06),

7. 10752668 - Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule (2020-08-25),

8. 10576103 - Immune cells defective for SUV39H1 (2020-03-03),

9. 9827216 - Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor (2017-11-28),

10. 7625573 - Sensitization process for antigen-presenting cells and means for implementing the process (2009-12-01),

11. 6899863 - Method for preparing membrane vesicles (2005-05-31),

12. 6685911 - Sensitization process for antigen-presenting cells and means for implementing the process (2004-02-03),

Title: Sebastian Amigorena - Innovative Inventor from Paris

Introduction: Sebastian Amigorena is a renowned inventor based in Paris, France, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Sebastian Amigorena holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Sebastian has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Sebastian has collaborated with top companies, innovative startups, and visionary entrepreneurs to bring his inventions to life and make a lasting impact on society.

Conclusion: Sebastian Amigorena's passion for innovation and his dedication to creating a better future through his inventions have solidified his reputation as a pioneering inventor in the global tech community.

Profile summary based on public USPTO records.